{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T10:05:25Z","timestamp":1745316325085},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"0","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2022-0616_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Citrin deficiency (CD) is an autosomal recessive disease caused by mutations of the <jats:italic>SLC25A13<\/jats:italic> gene, plasma bile acid profiles detected by liquid chromatography-tandem mass spectrometry (LC-MS\/MS) could be an efficient approach for early diagnosis of intrahepatic cholestasis. The aim of this study was to investigate the genetic testing and clinical characteristics of a series of patients with CD, and to analyse plasma bile acid profiles in CD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0616_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analysed data from 14 patients (12 males and 2 females, age 1\u201318\u00a0months, mean 3.6\u00a0months) with CD between 2015 and 2021, including demographics, biochemical parameters, genetic test results, treatment, and clinical outcomes. In addition, 30 cases (15 males and 15 females, age 1\u201320\u00a0months, mean 3.8\u00a0months) with idiopathic cholestasis (IC) served as a control group. Plasma 15 bile acid profiles were compared between the CD and IC groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0616_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eight different mutations of the <jats:italic>SLC25A13<\/jats:italic> gene were detected in the 14 patients diagnosed with CD, of which three novel variants of the <jats:italic>SLC25A13<\/jats:italic> gene were investigated, the c.1043C&gt;T (p.P348L) in exon11, the c.1216dupG (p.A406 Gfs*13) in exon12 and the c.135G&gt;C (p.L45F) in exon3. More than half of the patients with CD had prolonged neonatal jaundice, which was associated with significantly higher alpha-fetoprotein (AFP) levels, hyperlactatemia and hypoglycemia. The majority of patients were ultimately self-limited. Only one patient developed liver failure and died at the age of 1 year due to abnormal coagulation function. In addition, the levels of glycochenodeoxycholic acid (GCDCA), taurocholate (TCA), and taurochenodeoxycholic acid (TCDCA) were significantly increased in the CD group compared with those in the IC group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2022-0616_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Three novel variants of the <jats:italic>SLC25A13<\/jats:italic> gene were identified for the first time, providing a reliable molecular reference and expanding the <jats:italic>SLC25A13<\/jats:italic> gene spectrum in patients with CD. Plasma bile acid profiles could be a potential biomarker for non-invasive early diagnosis of patients with intrahepatic cholestasis caused by CD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2022-0616","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T20:05:37Z","timestamp":1683317137000},"source":"Crossref","is-referenced-by-count":1,"title":["Genetic and clinical features of patients with intrahepatic cholestasis caused by citrin deficiency"],"prefix":"10.1515","volume":"0","author":[{"given":"Wenjun","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology , Tian You Hospital Affiliated to Wuhan University of Science & Technology , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangling","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Genetics Center , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrine Genetic Metabolism in Children , Maternal and Child Health Hospital of Hubei Province , Wuhan , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"2023050520053076241_j_jpem-2022-0616_ref_001","doi-asserted-by":"crossref","unstructured":"Kobayashi, K, Sinasac, DS, Iijima, M, Boright, AP, Begum, L, Lee, JR, et al.. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 1999;22:159\u201363. https:\/\/doi.org\/10.1038\/9667.","DOI":"10.1038\/9667"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_002","doi-asserted-by":"crossref","unstructured":"Yoshiyuki, O, Toshihiro, O, Osamu, S, Ayano, I. Current treatment for citrin deficiency during NICCD and adaptation\/Compensationstages:Strategy to prevent CTLN2. Mol Genet Metabol 2019;127:175\u201383. https:\/\/doi.org\/10.1016\/j.ymgme.2019.06.004.","DOI":"10.1016\/j.ymgme.2019.06.004"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_003","doi-asserted-by":"crossref","unstructured":"Chen, R, Wang, XH, Fu, HY, Zhang, SR, Abudouxikuer, K, Saheki, T, et al.. Different regional distribution of SLC25A13 mutations in Chinese patients with neonatal intrahepatic cholestasis. World J Gastroenterol 2013;19:4545\u201351. https:\/\/doi.org\/10.3748\/wjg.v19.i28.4545.","DOI":"10.3748\/wjg.v19.i28.4545"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_004","doi-asserted-by":"crossref","unstructured":"Lin, WX, Zeng, HS, Zhang, ZH, Mao, M, Zheng, QQ, Zhao, ST, et al.. Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution. Sci Rep 2016;11:29732. https:\/\/doi.org\/10.1038\/srep29732.","DOI":"10.1038\/srep29732"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_005","doi-asserted-by":"crossref","unstructured":"Song, YZ, Li, BX, Chen, FP, Liu, SR, Sheng, JS, Ushikai, M, et al.. Neonatal intrahepatic cholestasis caused by citrin deficiency: clinical and laboratory investigation of 13 subjects in mainland of China. Dig Liver Dis 2009;41:683\u20139. https:\/\/doi.org\/10.1016\/j.dld.2008.11.014.","DOI":"10.1016\/j.dld.2008.11.014"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_006","doi-asserted-by":"crossref","unstructured":"Estrella, J, Wilcken, B, Carpenter, K, Bhattacharya, K, Tchan, M, Wiley, V. Expanded newborn screening in New South Wales:missed cases. J\u00a0Inherit Metab Dis 2014;37:881\u20137. https:\/\/doi.org\/10.1007\/s10545-014-9727-2.","DOI":"10.1007\/s10545-014-9727-2"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_007","doi-asserted-by":"crossref","unstructured":"Yang, CH, Chen, CY, Chou, YY, Chiu, HC, Tsai, WL, Shiesh, SC. Bile acid profiles in neonatal intrahepatic cholestasis caused by citrin deficiency. Clin Chim Acta 2017;475:28\u201335. https:\/\/doi.org\/10.1016\/j.cca.2017.10.005.","DOI":"10.1016\/j.cca.2017.10.005"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_008","doi-asserted-by":"crossref","unstructured":"Fu, XW, Xiao, Y, Golden, J, Niu, S, Gayer, CP. Serum bile acids profiling by liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and its application on pediatric liver and intestinal diseases. Clin Chem Lab Med 2019;58:787\u201397. https:\/\/doi.org\/10.1515\/cclm-2019-0354.","DOI":"10.1515\/cclm-2019-0354"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_009","doi-asserted-by":"crossref","unstructured":"Moyer, V, Freese, DK, Whitington, PF, Olson, AD, Brewer, F, Colletti, RB, et al.. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American society for pediatric Gastroenterology, Hepatology and nutrition. J Pediatr Gastroenterol Nutr 2004;39:115\u201328. https:\/\/doi.org\/10.1097\/00005176-200408000-00001.","DOI":"10.1097\/00005176-200408000-00001"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_010","doi-asserted-by":"crossref","unstructured":"Liu, Y, Rong, ZH, Xiang, D, Zhang, CL, Liu, D. Detection technologies and metabolic profiling of bile acids: a comprehensive review. Lipids Health Dis 2018;17:121. https:\/\/doi.org\/10.1186\/s12944-018-0774-9.","DOI":"10.1186\/s12944-018-0774-9"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_011","doi-asserted-by":"crossref","unstructured":"Song, YZ, Zhang, ZH, Lin, WX, Zhao, XJ, Deng, M, Ma, YL, et al.. SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. PLoS ONE 2013;8:e74544. https:\/\/doi.org\/10.1371\/journal.pone.0074544.","DOI":"10.1371\/journal.pone.0074544"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_012","doi-asserted-by":"crossref","unstructured":"Seak, HO, Beom, HL, Kim, GH, Choi, JH, Kim, KM, Yoo, HW, et al.. Biochemical and molecular characteristics of citrin deficiency in Korean children. J Hum Genet 2017;62:305\u20137. https:\/\/doi.org\/10.1038\/jhg.2016.131.","DOI":"10.1038\/jhg.2016.131"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_013","doi-asserted-by":"crossref","unstructured":"Melis, DK, Mehtap, K, Taha, RO, Cahit, BE, Gulin, E, Miray, K, et al.. Clinical findings in five Turkish patients with citrin deficiency and identification of a novel mutation on SLC25A13. J Pediatr Endocrinol Metab 2020;33:157\u201363. https:\/\/doi.org\/10.1515\/jpem-2019-0377.","DOI":"10.1515\/jpem-2019-0377"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_014","doi-asserted-by":"crossref","unstructured":"Wang, H, Shu, SN, Chen, C, Huang, ZH, Wang, DW. Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations. J\u00a0Pediatr Endocrinol Metab 2015;28:471\u20135. https:\/\/doi.org\/10.1515\/jpem-2014-0278.","DOI":"10.1515\/jpem-2014-0278"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_015","doi-asserted-by":"crossref","unstructured":"Palmieri, F, Monn\u00e9, M. Discoveries, metabolic roles and diseases of mitochondrial carriers: a review. Biochim Biophys Acta 2016;1863:2362\u201378. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.03.007.","DOI":"10.1016\/j.bbamcr.2016.03.007"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_016","doi-asserted-by":"crossref","unstructured":"Lin, YM, Liu, Y, Zhu, L, Le, KX, Shen, YY, Yang, CJ, et al.. Combining newborn metabolic and genetic screening for neonatal intrahepatic cholestasis caused by citrin deficiency. J Inherit Metab Dis 2020;43:467\u201377. https:\/\/doi.org\/10.1002\/jimd.12206.","DOI":"10.1002\/jimd.12206"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_017","doi-asserted-by":"crossref","unstructured":"Tamamori, A, Fujimoto, A, Okano, Y, Kobayashi, K, Saheki, T, Tagami, Y, et al.. Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency. Pediatr Res 2004;56:608\u201314. https:\/\/doi.org\/10.1203\/01.pdr.0000139713.64264.bc.","DOI":"10.1203\/01.PDR.0000139713.64264.BC"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_018","doi-asserted-by":"crossref","unstructured":"Pammi, M, Cope, J, Tarr, PI, Warner, BB, Morrow, AL, Mai, V, et al.. Intestinal dysbiosis in preterm infants preceding necrotizingenterocolitis: a systematic review and meta-analysis. Microbiome 2017;5:31. https:\/\/doi.org\/10.1186\/s40168-017-0248-8.","DOI":"10.1186\/s40168-017-0248-8"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_019","doi-asserted-by":"crossref","unstructured":"Teng, L, Ren, W, Jun, H, Xu, Y, Chen, Y, Cao, Y, et al.. Changes in plasma bile acid profiles after partial internal biliary diversion in PFIC2 patients. Ann Transl Med 2020;8:181\u20135. https:\/\/doi.org\/10.1016\/j.ajur.2019.03.006.","DOI":"10.21037\/atm.2020.01.103"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_020","doi-asserted-by":"crossref","unstructured":"Kejun, Z, Jun, W, Xie, GX, Zhou, Y, Yan, W, Pan, W, et al.. Distinct plasma bile acid profiles of biliary atresia and neonatal hepatitis syndrome. J\u00a0Proteome Res 2015;14:4844\u201350. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00676.","DOI":"10.1021\/acs.jproteome.5b00676"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_021","doi-asserted-by":"crossref","unstructured":"Li, T, Chiang, JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948\u201383. https:\/\/doi.org\/10.1124\/pr.113.008201.","DOI":"10.1124\/pr.113.008201"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_022","doi-asserted-by":"crossref","unstructured":"Merk, D, Sreeramulu, S, Kudlinzki, D, Saxena, K, Linhard, V, Gande, SL, et al.. Molecular tuning of farnesoid X receptor partial agonism. Nat Commun 2019;10:2915\u20136. https:\/\/doi.org\/10.1038\/s41467-019-10853-2.","DOI":"10.1038\/s41467-019-10853-2"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_023","doi-asserted-by":"crossref","unstructured":"Zhang, Y, Jackson, JP, St, CRR, Freeman, K, Brouwer, KR, Edwards, JE. Obeticholicacid, a selective farnesoid X receptor agonist, regulates bile acid homeostasis in sandwich-cultured human hepatocyts. Pharmacol Res Perspect 2017;5:e00329. https:\/\/doi.org\/10.1002\/prp2.329.","DOI":"10.1002\/prp2.329"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_024","doi-asserted-by":"crossref","unstructured":"Hayasaka, K, Numakura, C, Toyota, K, Kimura, T. Treatment with\u00a0lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency. J Inherit Metab Dis Rep 2012;2:37\u201344. https:\/\/doi.org\/10.1007\/8904_2011_42.","DOI":"10.1007\/8904_2011_42"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_025","doi-asserted-by":"crossref","unstructured":"Hayasaka, K. Metabolic basis and treatment of citrin deficiency. J Inherit Metab Dis 2021;44:110\u20137. https:\/\/doi.org\/10.1002\/jimd.12294.","DOI":"10.1002\/jimd.12294"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_026","doi-asserted-by":"crossref","unstructured":"Tamamori, A, Okano, Y, Ozaki, H, Fujimoto, A, Kajiwara, M, Fukuda, K, et al.. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur J Pediatr 2002;161:609\u201313. https:\/\/doi.org\/10.1007\/s00431-002-1045-2.","DOI":"10.1007\/s00431-002-1045-2"},{"key":"2023050520053076241_j_jpem-2022-0616_ref_027","doi-asserted-by":"crossref","unstructured":"Shigeta, T, Kasahara, M, Kimura, T, Fukuda, A, Sasaki, K, Arai, K, et al.. Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor. Pediatr Transplant 2010;14:E86\u20138. https:\/\/doi.org\/10.1111\/j.1399-3046.2009.01172.x.","DOI":"10.1111\/j.1399-3046.2009.01172.x"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0616\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0616\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T20:05:44Z","timestamp":1683317144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2022-0616\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":27,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2023,5,8]]}},"alternative-id":["10.1515\/jpem-2022-0616"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2022-0616","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]}}}